Breaks Categories: News

WednesdayApr 10, 2019 9:20 am

CBDNewsBreaks – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) Issues Update on Cannabis Facility Acquisition

TransCanna Holdings (CSE: TCAN) (FSE: TH8), an emerging cannabis branding, transportation and distribution company based in Canada, this morning provided an update concerning the company’s acquisition of a 196,000-square-foot vertically integrated cannabis facility. Per the update, TransCanna expects the closing of escrow for the acquisition to take place on or around Monday, April 15th. The company intends to provide an additional update upon the successful completion of the acquisition. To view the full press release, visit http://cnw.fm/L3E6m About TransCanna Holdings Inc. TransCanna Holdings Inc. is a Canadian-based company focused on providing integrated branding, transportation and distribution services, through its wholly-owned California…

Continue Reading

TuesdayApr 09, 2019 9:29 am

CBDNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Renews Senior Management Contracts, Cancels Options

Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) this morning announced its successful negotiation of renewal management contracts with chief executive officer Chris Bunka and president John Docherty. According to the update, the new 3-year term contracts, for which specific details can be found within regulatory filings, provide management continuity during this period of corporate growth while allowing the company to seamlessly pursue its business goals and create shareholder value. In addition, Lexaria announced that, effective April 5, 2019, it has reached agreements with certain optionees to cancel 1,140,000 stock options with exercise prices ranging…

Continue Reading

TuesdayApr 09, 2019 9:00 am

CBDNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Appoints Cannabis Industry Veteran with Passion, Deep Expertise to its Board

Chemistree Technology (CSE: CHM) (OTCQB: CHMJF) recently announced its appointment of Nicholas J. Zitelli to its board of directors. Zitelli is currently part-owner, director, and chief cannabis officer of Trans High Corporation (“THC”), the parent company for all HIGH TIMES brands, and is also the founder and CEO of the Cannabis Genetics Institute (“CGI”), a well-established research and development institution. Zitelli has authored hundreds of articles since 2007, under the penname of "Nico Escondido,” covering all cannabis science and technology aspects and garnering a reputation as an industry expert in the areas of garden technologies, cultivation, genetics, lab testing, and…

Continue Reading

TuesdayApr 09, 2019 8:30 am

CBDNewsBreaks – Organigram Holdings Inc. (TSX.V: OGI) (OTCQX: OGRMF) to Post Q2 2019 Results on April 15th

Organigram Holdings (TSX.V: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. recently announced that on Monday, April 15, 2019 the company will release its second quarter results for its fiscal year ended August 31, 2019. Organigram will also host a conference call to discuss the results on the same day at 8:00 AM ET. To join the call, dial 1-888-231-8191 for the toll free North American line or dial 647-427-7450 or 778-371-9827 for the international line. A telephone replay of the conference will be available until April 22nd that can be accessed by dialing 1-855-859-2056 and using the conference…

Continue Reading

MondayApr 08, 2019 10:14 am

CBDNewsBreaks – Generation Alpha Inc. (GNAL) Purchases Arizona Cultivation Facility in Effort to Fast-Track Operations in US Medical Cannabis Sector

Vertically integrated cannabis technology innovator, manufacturer and distributor Generation Alpha Inc. (OTCQB: GNAL) this morning announced its purchase of a roughly 46,000 sq. ft. facility in Phoenix, Arizona. According to the update, the facility is approved with a special use permit (“SUP”) for the cultivation and processing of medical cannabis and is ideally located less than 10 miles from Phoenix’s Sky Harbor International Airport. “This is an incredible deal for Generation Alpha,” GNAL CEO Alan Lien commented in the news release. “This facility, which has been locally permitted for medical cannabis cultivation and processing, will allow us to fast track…

Continue Reading

MondayApr 08, 2019 9:30 am

CBDNewsBreaks – SinglePoint Inc. (SING) Files First Annual Report with SEC, Reports 344% YOY Revenue Increase

SinglePoint Inc. (OTCQB: SING), a fully reporting technology company providing mobile payments, ancillary cannabis services and renewable energy solutions, this morning announced the filing of its first annual report with the SEC as a fully reporting issuer. Per the update, SinglePoint ended 2018 with an unaudited sales total of $1,154,671, marking an increase of 344 percent as compared to the previous year. The company attributes this growth to the success of its acquisition strategy. “We have spent a lot of time and effort to put the Company in a position to turn a profit in the very near future. With…

Continue Reading

MondayApr 08, 2019 8:30 am

CBDNewsBreaks – Organigram Holdings Inc. (TSX.V: OGI) (OTCQX: OGRMF) Provides Update Regarding Recent Executive Team Changes

Organigram Holdings (TSX.V: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc., on Sunday announced the appointment of James Cavanagh as the company's Chief of Staff. Cavanagh, a strategy and operations consultant, has worked with Canadian and international clients throughout various industries to drive growth and implement operational improvements. Cavanagh will work directly with the executive team members to ensure corporate priorities are maintained. Furthermore, Organigram announced the addition of Matt Rogers and Tina Shannon to the company's senior management team; the appointment of Ray Gracewood to the role of Senior Vice President, Marketing and Communications; the appointment of Helen…

Continue Reading

FridayApr 05, 2019 12:04 pm

CBDNewsBreaks – TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8) Closes C$16 Million Brokered Private Placement

Canada-based cannabis company TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8) late Thursday announced that it has closed its previously detailed and upsized brokered private placement of units, generating gross proceeds of C$16 million. Per the update, an aggregate of eight million units of the company were sold at a price of C$2.00 per unit, with each unit comprised of one common share of TransCanna and one half of one common share purchase warrant. TransCanna intends to use the net proceeds of the offering to fund an $8 million down payment for its proposed acquisition of a 196,000-square-foot cannabis facility. The…

Continue Reading

FridayApr 05, 2019 10:22 am

CBDNewsBreaks – The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (Frankfurt: YG3) Engages The Design Spot to Further Position in $22B Hemp and CBD Industry

The Yield Growth (CSE: BOSS) (OTCQB: BOSQF) (Frankfurt: YG3) on Thursday announced its appointment of specialist New York Agency The Design Spot for strategic graphic design counsel from overall brand direction to packaging, merchandising and point-of-sale deliverables. According to the update, this move to promote stand-out visual identity and branding is vital to differentiate in the growing hemp-CBD market, which could reach $22 billion by 2022 according to a new estimate from cannabis industry analysts the Brightfield Group. The Design Spot and its team of award-winning designers was chosen for notable experience with an emphasis on skin care, hair care,…

Continue Reading

FridayApr 05, 2019 9:32 am

CBDNewsBreaks – The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) Releases Q4 and Full Year 2018 Results

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) on Thursday announced its results for the fourth quarter and full year ended December 31, 2018. According to the update, the company sold nearly 406 kgs of premium cannabis despite having only 20 percent of its Kelowna 1 grow rooms operational in the fourth quarter of 2018. In addition, Flowr reported gross revenues of C$3.3 million and net revenues of C$2.9 million, realizing an average net price of C$7.08/gram after receiving its sales license in August 2018, and broke ground on the first-of-its-kind 50,000 square foot R&D Facility in partnership with The Scotts Miracle-Gro…

Continue Reading